BMY-14802
BMY-14802
BMY-14802 (pronunciation: B-M-Y-1-4-8-0-2), also known as alpha-ethyltryptamine, is a pharmacological compound with potential antipsychotic properties. It is a derivative of the naturally occurring amino acid tryptophan.
Etymology
The name BMY-14802 is derived from the compound's original designation in the research laboratories of Bristol-Myers Squibb, a leading pharmaceutical company. The compound was the 14,802nd synthesized in their labs, hence the numerical part of the name.
Pharmacology
BMY-14802 is a sigma receptor antagonist. Sigma receptors are a class of proteins found in the central nervous system that are thought to be involved in a variety of psychiatric disorders. By blocking these receptors, BMY-14802 may help to alleviate symptoms of these disorders.
Related Terms
- Antipsychotic: A class of medication primarily used to manage psychosis, including delusions, hallucinations, paranoia, or disordered thought.
- Sigma receptor: A class of proteins found in the central nervous system that are thought to be involved in a variety of psychiatric disorders.
- Central nervous system: The part of the nervous system consisting of the brain and spinal cord.
- Bristol-Myers Squibb: A leading pharmaceutical company.
See Also
External links
- Medical encyclopedia article on BMY-14802
- Wikipedia's article - BMY-14802
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski